ANL
Price
$10.30
Change
+$0.22 (+2.18%)
Updated
Feb 5, 02:23 PM (EDT)
Capitalization
370.11M
20 days until earnings call
Intraday BUY SELL Signals
LPCN
Price
$8.16
Change
-$0.02 (-0.24%)
Updated
Feb 5, 02:58 PM (EDT)
Capitalization
45.75M
Intraday BUY SELL Signals
Interact to see
Advertisement

ANL vs LPCN

Header iconANL vs LPCN Comparison
Open Charts ANL vs LPCNBanner chart's image
Adlai Nortye
Price$10.30
Change+$0.22 (+2.18%)
Volume$490
Capitalization370.11M
Lipocine
Price$8.16
Change-$0.02 (-0.24%)
Volume$200
Capitalization45.75M
ANL vs LPCN Comparison Chart in %
ANL
Daily Signal:
Gain/Loss:
LPCN
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANL vs. LPCN commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANL is a StrongBuy and LPCN is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (ANL: $10.08 vs. LPCN: $8.18)
Brand notoriety: ANL and LPCN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANL: 90% vs. LPCN: 41%
Market capitalization -- ANL: $370.11M vs. LPCN: $45.75M
ANL [@Biotechnology] is valued at $370.11M. LPCN’s [@Biotechnology] market capitalization is $45.75M. The market cap for tickers in the [@Biotechnology] industry ranges from $119.38B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANL’s FA Score shows that 0 FA rating(s) are green whileLPCN’s FA Score has 0 green FA rating(s).

  • ANL’s FA Score: 0 green, 5 red.
  • LPCN’s FA Score: 0 green, 5 red.
According to our system of comparison, LPCN is a better buy in the long-term than ANL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANL’s TA Score shows that 5 TA indicator(s) are bullish while LPCN’s TA Score has 3 bullish TA indicator(s).

  • ANL’s TA Score: 5 bullish, 3 bearish.
  • LPCN’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, ANL is a better buy in the short-term than LPCN.

Price Growth

ANL (@Biotechnology) experienced а +190.49% price change this week, while LPCN (@Biotechnology) price change was -13.53% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -5.81%. For the same industry, the average monthly price growth was -1.54%, and the average quarterly price growth was +30.06%.

Reported Earning Dates

ANL is expected to report earnings on Feb 25, 2026.

Industries' Descriptions

@Biotechnology (-5.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ANL($370M) has a higher market cap than LPCN($45.7M). ANL YTD gains are higher at: 609.859 vs. LPCN (1.868). LPCN has higher annual earnings (EBITDA): -6.25M vs. ANL (-49.89M). ANL has more cash in the bank: 98M vs. LPCN (15.1M). LPCN has less debt than ANL: LPCN (1.48M) vs ANL (39.5M). ANL has higher revenues than LPCN: ANL (5M) vs LPCN (4.32M).
ANLLPCNANL / LPCN
Capitalization370M45.7M810%
EBITDA-49.89M-6.25M798%
Gain YTD609.8591.86832,648%
P/E RatioN/AN/A-
Revenue5M4.32M116%
Total Cash98M15.1M649%
Total Debt39.5M1.48M2,665%
FUNDAMENTALS RATINGS
LPCN: Fundamental Ratings
LPCN
OUTLOOK RATING
1..100
79
VALUATION
overvalued / fair valued / undervalued
1..100
55
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
97
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANLLPCN
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
85%
Momentum
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
89%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
84%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
80%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 4 days ago
84%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
88%
Aroon
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
ANL
Daily Signal:
Gain/Loss:
LPCN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FFXDF17.590.43
+2.51%
Fairfax India Hldgs Corp
CFNB27.640.62
+2.29%
California First Leasing Corporation
ASRMF36.89N/A
N/A
Grupo Aeroportuario del Sureste S.A. de C.V.
FNCJF0.09N/A
N/A
Fancamp Exploration Ltd.
CDAUF10.18N/A
N/A
Compass Digital Acquisition Corp.

ANL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANL has been closely correlated with ATOS. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if ANL jumps, then ATOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANL
1D Price
Change %
ANL100%
+7.23%
ATOS - ANL
84%
Closely correlated
-4.34%
PMN - ANL
84%
Closely correlated
-1.57%
CANF - ANL
84%
Closely correlated
-0.25%
PHGE - ANL
82%
Closely correlated
-7.36%
ACET - ANL
82%
Closely correlated
-3.51%
More

LPCN and

Correlation & Price change

A.I.dvisor indicates that over the last year, LPCN has been closely correlated with PMN. These tickers have moved in lockstep 80% of the time. This A.I.-generated data suggests there is a high statistical probability that if LPCN jumps, then PMN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LPCN
1D Price
Change %
LPCN100%
-2.04%
PMN - LPCN
80%
Closely correlated
-1.57%
STRO - LPCN
79%
Closely correlated
+0.40%
PRAX - LPCN
79%
Closely correlated
-2.31%
ACET - LPCN
78%
Closely correlated
-3.51%
ANL - LPCN
77%
Closely correlated
+7.23%
More